August 27, 2026
Daily Market Report

Market Review: August 27, 2026

Closing Recap

Thursday, August 27, 2026

Index

Up/Down

%

Last

DJ Industrials

104.67

0.20%

53,568

S&P 500

55.08

0.72%

7,730

Nasdaq

411.16

1.14%

26,541

Russell 2000

8.46

0.28%

3,014

 

 

 

 

 

 

 

 

 

U.S. stock markets finished higher as earnings from tech giants Nvidia (NVDA) in semiconductors, and Salesforce (CRM), Okta (OKTA) and CrowdStrike (CRWD) in software lifted the tech trade as investors awaited the Fed’s Jackson Hole gathering. While the Nasdaq rose over 1% and the S&P 500 (SPX) +0.5%, it was primarily tech (XLK +3.17%) that did all the work as nine of the eleven S&P sectors finished lower amid the rotation into semis/software today, with Healthcare (XLV), Consumer Discretionary (XLY), and Consumer Staples (XLP) all down over 1%. Nvidia (NVDA) stock leaped 8% higher after the company reported an earnings beat and signaled strong AI demand throughout next year. Retailers DLTR, BBW, and BURL all declined on earnings results. With the AI bellwether’s report in the rearview mirror, the focus now turns to the Federal Reserve’s Jackson Hole Symposium, where central bank officials will debate the path of interest rate policy. Fed Chairman Kevin Warsh is expected to deliver a speech on Friday, The dollar and Treasury yields were little changed today, while oil pushed higher and Bitcoin stayed above $80K.

 

Ahead of Fed Chairman Kevin Warsh speech at the Fed Jackson Hole symposium tomorrow morning, Federal Reserve Bank of Cleveland President Beth Hammack said Thursday worries about persistently high inflation continue to argue in favor of the central bank raising interest rates. “We’ve got a lot of time before our next meeting, so I don’t want to prejudge anything,” Hammack said in a CNBC interview. “But I believe now is the time to act” given inflation’s continued trend above the 2% target, she said. Hammack dissented in favor of an interest rate increase at the Fed’s late July policy meeting. Meanwhile, Boston Fed President Susan Collins said in an interview on the sidelines of the Kansas City Fed’s annual symposium in Wyoming that “I am open to supporting an increase if I see conditions as not providing that evidence of continued disinflation that I‘m looking for.”

Economic Data

  • Weekly Jobless Claims fell to 203,000 Aug 22 week (vs. consensus 208,000) from 207,000 prior week (previous 206,000); the 4-week moving average climbed to 205,500 from 204,250 prior week; continued claims fell to 1.778M from 1.796M prior and vs. est. 1.790M.
  • August Kansas City Fed Manufacturing Index up to +10 vs. +10 est. & +9 prior … new orders strong at +16 (+10 prior), shipments eased a bit to +17 (+20 prior); prices paid up to +55 (+52 prior).

Commodities

  • Gold prices were steady with December gold rises $10.70, or +0.23%, to settle at $4,664.00 while September silver gained $1.41, or +2.07%, to settle at $69.43 an ounce. Gold edged higher after prices climbed to a more than three-month peak this week, with markets awaiting Federal Reserve Chair Kevin Warsh’s speech at Jackson Hole tomorrow morning for clues to his roadmap on inflation and monetary policy.
  • @GlobalMktObserv noted on X, “The largest US physically gold-backed ETF, $GLD, attracted +$3.4 billion in inflows last week, the 4th-largest weekly intake on record. This put the fund in the top 10 of the ETF flow rankings last week. So far this month, $GLD has attracted +$5.8 billion in inflows, putting it on track for its largest monthly inflow on record. That would exceed the combined January and February inflows of +$2.6 billion and +$2.5 billion during the gold market frenzy.”
  • U.S. WTI crude oil futures settle at $83.53/bbl, up $1.30, or 1.58% and brent crude gained $1.86 or 2.12% to settle at $89.70 per barrel as all was quiet the last few days on the U.S./Iran headlines with no new changes of late. A WSJ report said U.S. President Trump is not interested in returning to terms of a memorandum of understanding reached with Iran in June.

Currencies & Treasuries

  • The U.S. dollar was little changed after a round of economic data, while attention began to shift towards a speech by Federal Reserve Chair Kevin Warsh at the Jackson Hole symposium. Warsh is scheduled to speak at the gathering of central bankers on Friday, where investors will watch for clues on how policymakers plan to navigate a landscape of inflation/higher Treasury yields. The dollar has rebounded from sharp declines in the prior week after U.S. Treasury Secretary Scott Bessent said the Treasury would double the size of quarterly repurchases of longer-dated bonds.

 

Macro

Up/Down

Last

WTI Crude

1.30

83.53

Brent

1.86

89.70

Gold

10.70

4,664.00

EUR/USD

-0.0002

1.1647

JPY/USD

0.12

159.41

10-Year Note

0.008

4.672%

 

Sector News Breakdown

Retail, Consumer Staples & Restaurants:

  • Discount/Dollar stories: mixed reactions as DG rises after raised its annual comp sales forecast to range of 2.5%-2.9%, vs. prior forecast of 2.2%-2.7% after posting Q2 comp sales growth +3.5%; also raises FY26 EPS view to $7.80-$8.00 from $7.20-$7.45 and ups FY26 net sales growth view to 4%-4.3% from 3.7%-4.2%. DLTR shares fell as Q2 beat EPS/sales helped by tariff benefit and raises FY26 adj EPS view to $7.70-$8.05 from $6.70-$7.10 (est. $7.04) but only affirms FY26 annual net sales and comparable sales forecasts amid macroeconomic uncertainty weighing on consumer spending.
  • Off Price Retail: last of the group reported today (TJX, ROST reported recently) as BURL Q2 adj EPS $2.37 tops consensus $2.18 on sales of $3B as raises full-year adj EPS guidance to $11.77-$11.97 and expects full-year comp sales growth of 3%-4%, but shares fell as guided Q3 results below views with EPS $1.60-$1.70, vs. consensus $2.03 and Q3 rev growth 9%-11% from $2.71B last year (est. $2.99B).
  • Specialty retailers: BBW shares were weak after results as Q2 revs fell -7% y/y and EPS also down on a y/y basis and lowers FY26 revenue view to $500M-$525M from $530M-$550M (est. $538.78M) and lowered its FY26 pre-tax income view to $60M-$68M from $72M-$78M; said increased promotional activity contributed to lower gross margin in Q2.
  • Electronic Retailers: BBY shares fell despite beat and raise as reported Q2 adj EPS $1.47 vs. est. $1.33 on revs $9.78B vs. est. $9.59B and guides FY adj EPS in the range of $6.70-$6.90, compared with prior guidance of $6.30-$6.60 on better rev view of $42.3B-$42.8B; said in Q2, incurred $6M reduction to restructuring charges versus $114M of restructuring charges last year.

Consumer Staples

  • Food & Beverage sector: HRL posted mixed results/guidance as adjusted EPS of $0.37 topped a Street estimate of $0.35 and management lifted the lower end of the FY26 EPS range. On the negative side, organic sales growth declined 2% and management lowered full-year targets. Pernod (PRNDY) said it now expects to achieve only the lower end of its long-term sales target through 2029; said Overweight expects sales growth at the lower end of its 3% to 6% target range through 2029; sales in the U.S. and China fell 14% and 19%, respectively, in the year ended June 30. CELH was downgraded to Hold from Buy at Deutsche Bank with $35 PT saying expectations are rising faster than evidence and says fundamental challenges have continued to mount.
  • Restaurant sector: WEN shares tumbled after Reuters reported Nelson Peltz’s Trian Fund Management has no plans to make a take-private bid for Wendy’s at this time. The move comes after the investment firm, a longtime Wendy’s shareholder with around 16% of the fast food chain, was earlier this month reported by Reuters and others to be working on preparing a bid with the help of a consortium of investors. https://tinyurl.com/yb68p6b7 ; casual dining and restaurant stocks were down broadly on the day with DRI, EAT, WING, BJRI, RRGB all notably lower.

Energy

  • Solar sector: FSLR was upgraded to Outperform from Market Perform with a $265 price target at BMO Capital as thinks the ~16% post-Section 232 selloff has overshot to the downside: the tariff/MIP framework should lift U.S. module ASPs, giving a sold-out FSLR a multi-quarter window to book 2029+ volumes at better prices, even as margin headwinds persist into 2027. CSIQ reported a wider Q2 EPS loss (-$1.40) vs. est. loss (-$1.23); Q2 revenue $1.21B, tops consensus $1.14B but guides Q3 revs $1.3B-$1.5B.
  • Power sector: BWXT was upgraded to Equal Weight at Wells Fargo ahead of its investor day Sept 29 where WELLS expects a multi-year forecast for MSD- HSD revenue & HSD+ EBITDA growth, roughly in line with consensus expectations. Piper noted it has been a tumultuous two weeks for the Power Services group as SEI has fallen 21% since 8/17/26 with LBRT -17%, PUMP -17%, KGS -9%, and AESI -6%, as a combination of Ai data center moratoriums and publicity around Equipment/permits have given investor pause. Ai data center moratoriums in Texas, Pennsylvania, and Michigan with additional States pushing back on development, have clearly indicated data Centers will be a political hot button issue for November midterms. Furthermore, publicity questioning power Generation Equipment performance and emission related permits has given investors pause on the Ai related trade. TE receives approval to develop data center at Giga Arctic Campus in Norway; expects 50 mw data center operational in 2027 with expansion potential; holds 50-year lease with extension options on giga arctic site; engaged in conversations with multiple parties to explore options. EOSE said it will consolidate Battery manufacturing operations at its Thorn Hill facility in Pennsylvania; says the move is expected to reduce conversion costs by about 10% to 15%, with benefits beginning in 2027.
  • MLPs and Pipeline sector: ENB said it had agreed to form a joint venture with KKR and APO to invest about C$2.7 billion ($1.95 billion) in expansions of its Westcoast natural gas pipeline system in British Columbia. Demand for natural gas infrastructure in Western Canada and the U.S. Pacific Northwest is also growing, with Enbridge’s Westcoast system providing a route to international LNG markets.

Banks, Brokers, Asset Managers:

  • Bank sector: RF was downgraded to Hold from Buy at Deutsche Bank as outline the bull and bear cases surrounding shares. The firm said despite a solid long-term track record it’s unclear to them what could drive meaningful further upside to either earnings or the stock. Revenue growth has been sluggish the past four quarters, up 3-4% on a YoY basis, on average (using adj. revenues per management) vs 7-8% average growth at peers. TD beat estimates on better-than-expected performance at its capital-markets business and across all its divisions, while CM, RY also out with earnings this morning in the Canadian banking sector.
  • REIT sector: LTC was upgraded to Buy from Hold at Deutsche Bank as see poised for earnings growth acceleration & multiple expansion beyond ’26 after recently took the management team on a non-deal roadshow (NDR) in Chicago. EXR upgraded from Market Perform to Outperform at BMO Capital calling it their top pick W/ $170 PT and SMA downgraded to Market Perform. MAC was upgraded to Overweight from Neutral at Piper as its revised 2027 estimate as likes that management is starting down the path to unencumbering its wholly owned assets.
  • Crypto sector: MSTR shares surged as Bitcoin prices topped $80,000 again, as MSTR approaching its 200dma resistance of $141.60 (has not been above 200dma since October 2025); COIN also advanced and also approaching its 200dma resistance which stands at $196 (hasn’t been above 200dma since November 2025); Bitcoin miners along with other names in the space like BMNR, IBIT, HOOD outperformed.
  • FinTech/Payments: XYZ shares rose after positive comments from Cleveland Research saying seller momentum remains strong with some further acceleration driven by continued domestic share gains. Meanwhile, the firm was cautious on FOUR saying their work remains cautious on restaurant share loss and continued distribution pressure/churn.
  • Insurance sector: PRI was downgraded to Hold from Buy at Truist and lower PT to $320 from $370 citing concern that Primerica’s recent underperformance in new Term Life sales will restrain topline expansion, which may no longer be offset by ISP upside, depending on the S&P 500.

Biotech & Pharma:

  • AZN said its asthma drug Tezspire met the main goals of a late-stage trial in patients with a chronic inflammatory disorder of the oesophagus. Tezspire, developed with AMGN, significantly reduced inflammation in the oesophagus and eased difficulty in swallowing versus a placebo at 52 weeks in patients with eosinophilic esophagitis, the study showed.
  • CELU shares jump to 4-month highs after saying earlier it will manufacture Dezawa MuseCells, an experimental cell therapy platform, and related products in the U.S. under a collaboration with MuseCell Innovations
  • MRNA announces proposed private placement of $2.0B of convertible Senior notes, which pressured shares this morning.
  • NVO downgraded to Sell from Hold at Deutsche Bank and cut tgt saying ziltivekimab is now effectively out of the picture while the Medicare prescription upside seems limited and the firm is concerned over Novo returning to growth in 2027 and patent cliffs longer term.

Healthcare Services & MedTech movers:

  • Healthcare Technology sector: VEEV delivered a strong Q2 with total revs ~2.5% above consensus and R&D subscription revenue growth of 19% above consensus of 17%; also Q2 normalized billings came in 4.7% above consensus and raised its FY27 billings guide by 1.2% alongside revenue and adj. EBIT/also issued F3Q guidance that was above consensus.
  • Life Sciences & Tools sector: WAT was upgraded to Overweight from Neutral at Piper and raise PT to $480 from $400 saying they believe the $7–9B global mass spectrometry market is entering a durable instrument replacement Cycle. Piper believes WAT, TMO, A should all benefit from this proteomics-led growth, but believes WAT is best positioned in mass spectrometry through its strength in regulated Pharma QA/QC, targeted quantitation and Integrated UPLC–MS software.
  • Medical Equipment: Agilent (A) delivered strong results for Q3 and raised guidance; core organic growth of 7.3% was above guidance of 4.4%-5.9% and consensus of 5.4%; showed an acceleration in Pharma, which grew 12% (6% in Q2, 7% in Q1). Some meaningful tailwind to Pharma performance was China strength and Specialty CDMO growing 30%.

Transports

  • Transport sector: Bank America notes LTLs (XPO, SAIA, ODFL, ARCB) are set to post mid-3Q updates beginning next week. Carriers see limited near-term Can/US tariff impacts, yet negotiations & consumer impacts fluid; FTR rail/truck conf next week. Key Data: Week 33 Carloads: 5.1% vs 3.8% last week; Truckload Spot=$2.02 v $2.05; DAT Load-Truck Ratio= 9.61 v 9.56 last week.
  • Materials sector: in lithium space, SQM was upgraded to Buy at Citigroup based on the Lithium market likely to remain in deficit in 2026 and return to balance in 2027 and positive near-term outlook as restocking and further export front-loading support a recovery in prices. Precious metal miners AG, FSM, HL, CDE outperformed.
  • Industrials and Machinery: TITN shares fell after results as Q2 revenue fell y/y to $496.4M but beat analyst expectations of $484M while posted a wider net loss as revenue declined and operating expenses rose; gross margin improved 150 bps y/y as inventory actions lifted equipment margins.

Semiconductors, Hardware and AI:

  • Semiconductors: it was all about NVDA as Q2 results solidly beat ($96.2B/$2.22 vs Street at $92.3B/$2.09). Datacenter upside on continued Blackwell momentum with strength across both Hyperscale customers (up 13% QoQ and 102% YoY) and ACIE customers (up ~25% QoQ and 138% YoY). Edge Computing revenues were also above consensus ($7.2B vs Street at consensus $6.6B). Guidance was once again well above expectations ($108.0B/~$2.46 vs Street $104.6B/ $2.36) with datacenter likely at $100B+ amid strong Rubin ramp (seen at ~20% of segment revs). NVDA also upticked FY28 expectations, with sales now seen growing by ~70% YoY, significantly ahead of current expectations. Recent gross margin worries given memory pricing Dynamics did prove correct with margins guided down somewhat (74% in Q3 bottoming to ~71-72% in Q4).
  • The Trump administration is considering broad new semiconductor tariffs that could extend to chip-containing products such as laptops and data-center servers, potentially raising AI infrastructure costs while linking tariff relief to U.S. manufacturing investment – Politico reported overnight.
  • Memory sector benefits early from NVDA results while news also out that Kioxia (KXIAY) and SNDK to invest over $31B in Japan, continuing leadership in memory industry. However, SNDK, MU, WDC all gave up early gains and reversed lower by mid-afternoon.
  • AI sector: Claude maker Anthropic is weighing allowing its existing shareholders sell some stock in its blockbuster IPO while also mulling longer-than-usual lockup periods for sales after it goes public, The Information reported.
  • Hardware & Components sector: HPQ reported FQ3 revs/EPS of $15.7B/$0.83, above Street at $14.4B/$0.66, and raised F26 EPS guide to $3.19-$3.29; overall results mixed, with an EPS beat but concerning margin trends in PCs and Print as Bank America noted the outlook as challenged by rising memory costs, demand elasticity from higher pricing and FQ4 PS OM expected below FQ3.
  • Storage sector: NTNX delivered Q4 revenue of $757M, 2% above the high end of guidance and up 16% YoY as ARR reached $2.549B, up 16%, with growth accelerating sequentially, while NRR held at 106%. Mgmt said saw no unusual pull-ins or future-start-date catch-up; FY26 TCV bookings grew in the high teens versus 12% revenue growth.

Software movers:

  • Security Software: big day for the cyber sector behind better results/guidance from CRWD and OKTA as both surge lifting the complex (PANW, ZS, CHKP). OKTA delivered a strong Q2, with accelerating cRPO growth (14.1% Y/y cRPO growth that accelerated vs 12.2% last qtr and topped consensus at 10.8%), record non-Q4 bookings, and improving enterprise and new-product momentum; also raised FY27 guidance across revenue, operating Income, EPS, and free cash flow. CRWD Q2 ARR rose 25% y/y, beating by $46M, the largest beat in several years per Keybanc, and raised FY ARR by $63M, on top of an already large raise in FQ1; Q2 $333M NNARR 51% YoY (>Q4’26 high watermark), and FY ARR/NNARR growth upped ~1pt/~6pts to 26%/34% above views. TENB will replace LEG in the S&P SmallCap 600 effective prior to the opening of trading on Monday, August 31. S&P MidCap 400 constituent SGI is acquiring Leggett & Platt.
  • SaaS software sector: CRM shares rallied behind results and Anthropic expanded their partnership with Claudeforce, a new Claude integration that lets sales teams access Salesforce data and take actions directly inside Claude. Q2 results were highlighted by upside to cRPO results and guidance and management’s reiteration that the business is set to reaccelerate in 2H:FY27. Agentforce and related Ai metrics continue showing robust growth; raised the FY guide by $100M organically. (the group was broadly higher in sympathy NOW, TEAM, MNDY, HUBS, MDB, etc.)
  • Quantum sector: INFQ shares active after NASA awards Co $20M follow-on contract to build a space-based Quantum Gravity sensor, bringing its investment in the program to $40M.

_________________________________________________________________

Market commentary provided by Hammerstone Markets, Inc, a firm separate from and not affiliated with Regal Securities. Regal Securities has not participated in the creation of the content, and does not explicitly or implicitly endorse the content.